A detailed history of Jupiter Asset Management LTD transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Jupiter Asset Management LTD holds 351,977 shares of ARCT stock, worth $5.64 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
351,977
Previous 352,550 0.16%
Holding current value
$5.64 Million
Previous $8.58 Million 4.83%
% of portfolio
0.07%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$18.08 - $25.38 $10,359 - $14,542
-573 Reduced 0.16%
351,977 $8.17 Million
Q2 2024

Aug 08, 2024

SELL
$24.35 - $44.39 $238,483 - $434,755
-9,794 Reduced 2.7%
352,550 $8.58 Million
Q4 2023

Feb 09, 2024

BUY
$17.71 - $32.97 $2.97 Million - $5.52 Million
167,563 Added 86.03%
362,344 $11.4 Million
Q3 2023

Nov 09, 2023

BUY
$25.44 - $37.35 $4.96 Million - $7.28 Million
194,781 New
194,781 $4.98 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $426M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.